The ratings agency said in a March 18 report that it predicts any credit implications from the attack are likely to be limited to smaller companies due to their “limited financial flexibility to withstand even temporary cash flow disruptions.” These companies tend to be rated in the “CCC” to low-to-mid “B” categories, which indicates low margins of safety.
Fitch said it assumes higher-rated companies, which typically are publicly traded, have the flexibility to withstand the disruptions.
“This is supported by most publicly traded issuers not viewing the event as material enough to warrant filing 8-Ks,” Fitch said in the report, adding that more will be known about the attack’s financial implications after first-quarter 2024 earnings results are reported.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
